CANADA LIFE ASSURANCE Co Sells 19,078 Shares of Colgate-Palmolive (NYSE:CL)

CANADA LIFE ASSURANCE Co reduced its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 2.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 818,506 shares of the company’s stock after selling 19,078 shares during the quarter. CANADA LIFE ASSURANCE Co owned about 0.10% of Colgate-Palmolive worth $73,751,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in CL. Union Savings Bank increased its stake in Colgate-Palmolive by 76.6% during the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after acquiring an additional 134 shares during the last quarter. Avion Wealth boosted its position in shares of Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after buying an additional 175 shares during the period. Atlantic Edge Private Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $32,000. PSI Advisors LLC boosted its position in shares of Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after buying an additional 348 shares during the period. Finally, Core Wealth Advisors Inc. boosted its position in shares of Colgate-Palmolive by 56.6% during the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after buying an additional 146 shares during the period. 80.41% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on CL shares. Evercore ISI boosted their target price on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. BNP Paribas started coverage on Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 target price for the company. Citigroup boosted their target price on Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Bank of America boosted their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Finally, Argus boosted their price target on Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a report on Wednesday, May 15th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $98.58.

Check Out Our Latest Analysis on CL

Colgate-Palmolive Stock Up 0.0 %

Shares of CL stock traded up $0.02 during trading hours on Wednesday, reaching $96.57. 4,880,324 shares of the company’s stock were exchanged, compared to its average volume of 4,377,431. The stock’s 50 day moving average is $95.68 and its 200-day moving average is $89.89. The company has a market cap of $79.23 billion, a price-to-earnings ratio of 30.56, a P/E/G ratio of 3.53 and a beta of 0.39. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $99.63.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same period in the prior year, the firm posted $0.73 earnings per share. The business’s quarterly revenue was up 6.2% on a year-over-year basis. Analysts predict that Colgate-Palmolive will post 3.54 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s payout ratio is 63.29%.

Insider Activity at Colgate-Palmolive

In related news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider John W. Kooyman sold 3,497 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the sale, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.